These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 31571225
1. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases. Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM, other members of the US Neuroendocrine Tumor Study Group. J Surg Oncol; 2019 Dec; 120(7):1071-1079. PubMed ID: 31571225 [Abstract] [Full Text] [Related]
2. Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors. Jiang Y, Jin JB, Zhan Q, Deng XX, Shen BY. Chin Med J (Engl); 2015 Dec 20; 128(24):3335-44. PubMed ID: 26668149 [Abstract] [Full Text] [Related]
3. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM. Ann Surg Oncol; 2020 Apr 20; 27(4):1203-1212. PubMed ID: 31838609 [Abstract] [Full Text] [Related]
4. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis. Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, Weber SM, Fields RC, Idrees K, Cho CS, Shen F, Pawlik TM, and other members of the U.S. Neuroendocrine Tumor Study Group. J Surg Oncol; 2019 Dec 20; 120(7):1080-1086. PubMed ID: 31468550 [Abstract] [Full Text] [Related]
5. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK. Ann Surg Oncol; 2019 Aug 20; 26(8):2517-2524. PubMed ID: 31004295 [Abstract] [Full Text] [Related]
6. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis. Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM. Ann Surg; 2021 Jul 01; 274(1):e28-e35. PubMed ID: 31356277 [Abstract] [Full Text] [Related]
14. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors. Zhang Z, Liu M, Ji S, Luo G, Xu W, Liu W, Hu Q, Sun Q, Ye Z, Qin Y, Fan G, Yu X, Xu X. Pancreas; 2020 Mar 01; 49(3):381-386. PubMed ID: 32132507 [Abstract] [Full Text] [Related]
16. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors. Tan QQ, Wang X, Yang L, Chen YH, Tan CL, Zhu XM, Ke NW, Liu XB. Medicine (Baltimore); 2020 Jun 12; 99(24):e20324. PubMed ID: 32541455 [Abstract] [Full Text] [Related]